Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released.
  1. David Cyranoski

    1. David Cyranoski reports for Nature from Shanghai, China.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Smriti Mallapaty
    View author publications

    You can also search for this author in PubMed  Google Scholar

The UK trial of a leading coronavirus vaccine, which was abruptly halted because of safety concerns, restarted on Saturday after the university conducting the trial said an independent committee found that it was safe to do so.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 585, 331-332 (2020)

doi: https://doi.org/10.1038/d41586-020-02633-6

Updates & Corrections

  • Update 15 September 2020: The story has been updated with the news that AZD1222 vaccine trials in Brazil have restarted.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links